PlainRecalls
FDA Drug Low Class III Terminated

Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, Rx only, packaged in 6.0 kg drums (labeled as 6,000 kg), Bayer Schering Pharma AG, D-13342 Berlin

Reported: July 24, 2013 Initiated: June 13, 2013 #D-807-2013

Product Description

Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, Rx only, packaged in 6.0 kg drums (labeled as 6,000 kg), Bayer Schering Pharma AG, D-13342 Berlin

Reason for Recall

Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.

Details

Units Affected
194.62 kg
Distribution
NY, CA
Location
Morristown, NJ

Frequently Asked Questions

What product was recalled?
Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, Rx only, packaged in 6.0 kg drums (labeled as 6,000 kg), Bayer Schering Pharma AG, D-13342 Berlin. Recalled by Bayer HealthCare Pharmaceuticals Inc.. Units affected: 194.62 kg.
Why was this product recalled?
Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 24, 2013. Severity: Low. Recall number: D-807-2013.